Submitted by Anonymous (not verified) on 13 September 2023 - 13:16
Human medicines European public assessment report (EPAR): Beovu, brolucizumab, Wet Macular Degeneration, Date of authorisation: 13/02/2020, Revision: 10, Status: Authorised
Source: